Welcome to the first edition of The Fantasy Football ADP Injury Index powered by our new partner SportsMedAnalytics! In this article, we have provided you with a detailed buy/sell injury index based on the current Razzball.com ADP. Below you will find a list of players who are coming off an injury-shortened 2021 season. Not all these players had major injuries, but have complied injuries over the past few seasons.
This article aims to help you decide if you should draft these players based on their current ADP. Later in the article, we have provided overviews and links to more information on some of these players. If you have further questions about the injured players in this article, you can find SportsMedAnalytics on Twitter! Â
Rank | Player | Pos | Team | Consensus ADP |
ADP Injury Index Powered By SportsMedAnalytics |
---|---|---|---|---|---|
2 | Christian McCaffrey | RB | CAR | 3.3 | Buy |
6 | Derrick Henry | RB | TEN | 7 | Buy |
9 | Dalvin Cook | RB | MIN | 8.9 | Buy |
13 | D’Andre Swift | RB | DET | 15.8 | Buy |
16 | Deebo Samuel | WR | SF | 17.9 | Sell |
21 | Saquon Barkley | RB | NYG | 21.9 | Buy |
23 | Leonard Fournette | RB | TB | 23 | Sell |
33 | Cam Akers | RB | LAR | 36.6 | Sell |
34 | Ezekiel Elliott | RB | DAL | 37 | Buy |
44 | Travis Etienne | RB | JAC | 46.5 | Buy |
46 | Darren Waller | TE | LV | 49.7 | Buy |
51 | J.K. Dobbins | RB | BAL | 56.1 | Buy w/caution |
52 | Jerry Jeudy | WR | DEN | 56.5 | Buy |
55 | Allen Robinson | WR | LAR | 58 | Buy |
60 | Chris Godwin | WR | TB | 64.1 | Sell |
62 | Joe Burrow | QB | CIN | 65.3 | Buy |
68 | Michael Thomas | WR | NO | 70.6 | Buy |
70 | Rashod Bateman | WR | BAL | 73.9 | Buy |
77 | DeAndre Hopkins | WR | ARI | 81.2 | Buy |
78 | Dak Prescott | QB | DAL | 82.4 | Buy |
108 | Robert Woods | WR | TEN | 110.7 | Sell |
120 | James Robinson | RB | JAC | 129.1 | Sell |
135 | Michael Gallup | WR | DAL | 138.5 | Sell |
145 | Julio Jones | WR | TB | 147.1 | Sell |
148 | D.J. Chark | WR | DET | 151.4 | Buy |
150 | Jameson Williams | WR | DET | 151.6 | Sell |
157 | Jameis Winston | QB | NO | 157.3 | Buy |
163 | Raheem Mostert | RB | MIA | 164.6 | Buy |
173 | Robert Tonyan Jr. | TE | GB | 174.1 | Sell |
Â
Player: Christian McCaffrey
Razzball Consensus ADP: 3.5
ADP Buy/Sell: Buy
The last 2 years have been tough for CMC owners. 2021 was derailed by a hamstring and ankle. 2020 was similar but different, with a combination of ankle and shoulder sprains + a glute strain. Fortunately, there’s not a pattern or long-term detriment expected here. RBs miss a lot of time, but he is no higher risk than anyone else.
Player: Derrick Henry
Razzball Consensus ADP: 7
ADP Buy/Sell: Buy
Derrick Henry is not at higher risk because of last year’s Jones fracture. Re-injury rates are ~10%, with no long-term performance impact expected. Age + cumulative risk of large volumes of carries are considerations, but there is data to suggest that Henry is part of a “high volume, high durability” group of RBs who can sustain the heavy workloads. Low-medium risk.
Player: Dalvin Cook
Razzball Consensus ADP: 8.9
ADP Buy/Sell: Buy
Dalvin Cook’s 2021 injuries aren’t the type to linger. Check out the link above for the full breakdown of Cook’s outlook for 2022.
Player: D’Andre Swift
Razzball Consensus ADP: 15.8
ADP Buy/Sell: Buy
D’Andre Swift missed 4 games and was in and out of others in 2021 for injury. However, neither his groin strain nor shoulder sprain is expected to recur. Could be a huge value with many owners not looking into the injury history.
Player: Deebo Samuel
Razzball Consensus ADP: 17.9
ADP Buy/Sell: Sell
We’re out on Deebo Samuel, and it has nothing to do with the talent. If he runs the ball as much as ’21, he’s at a 20% increased injury risk compared to other WRs. If he doesn’t, his productivity is unlikely to be the same. Either way, this is a sell.
Player: Saquon Barkley
Razzball Consensus ADP: 21.9
ADP Buy/Sell: Buy
ACL data tells us that we should’ve expected a subpar 2021, and the Giants’ 4th worst O-line didn’t make matters better. Now the Giants have upgraded, and Saquon Barkley is poised to bounce back. Big-time buy.
Player: Cam Akers
Razzball Consensus ADP: 36.6
ADP Buy/Sell: Sell
Achilles’ tears are brutal, often showing multi-year declines for RBs. Luckily, Cam Akers is young and had the makings of an elite player before the injury. He should get back to pre-injury levels, but it will probably take him until ~Week 8 to do so. Sell.
Player: Ezekiel Elliott
Razzball Consensus ADP: 37
ADP Buy/Sell: Buy
Zeke has been consistently near the top of the league in production, but he played through a PCL tear in ’21. As expected, his stats suffered, so his current ADP is equivalent to his prior floor. Probably back to full strength with a favorable bounce-back expected.
Player: Travis Etienne
Razzball Consensus ADP: 46.5
ADP Buy/Sell: Buy
Dual-threat ability, strong pre-injury athleticism, and the December Achilles tear for James Robinson all lead to a strong “buy” recommendation. Check out the full breakdown in the link.
Player: Darren Waller
Razzball Consensus ADP: 49.7
ADP Buy/Sell: Buy
Waller’s 2021 was impacted by an IT band strain, which isn’t expected to recur or cause durability concerns. His previous two years were tier 1 numbers, and that’s more likely what we should expect in ’22.
Player: J.K. Dobbins
Razzball Consensus ADP: 56.1
ADP Buy/Sell: Buy without w/caution
The SportsMedAnalytics machine-learning algorithm predicts return and performance after injury amongst NFL players. From this, we know that ACL tears average 10 months out for RBs. But Dobbins’ injury was more severe since it involved an additional ligament, the LCL. Combined injuries to ACL + LCL generally take closer to 15 months to get back. Read more now at the link above.Â
Player: Jerry Jeudy
Razzball Consensus ADP: 56.5
ADP Buy/Sell: Buy
Jerry Jeudy isn’t any higher risk than anyone else. The high ankle doesn’t carry into ’22, and he otherwise doesn’t have any concerning injury patterns here.
Â
Player: Chris Godwin
Razzball Consensus ADP: 64.1
ADP Buy/Sell: Sell
Chris Godwin has elite talent, but the price is too much for a guy who had ACL surgery in January. The average timeline would put his return to the field in mid-October, but the SportsMedAnalytics algorithm projects his production to lag by about a month.
Player: Michael Thomas
Razzball Consensus ADP: 70.6
ADP Buy/Sell: Buy
MT this far out from his surgery should be fully recovered. Yes, losing a step is a realistic possibility if you don’t play for almost 2 years, but Thomas at his current price is going closer to his floor than his ceiling.
Â
Player: DeAndre Hopkins
Razzball Consensus ADP: 81.2
ADP Buy/Sell: Buy
The MCL injury isn’t like the ACL. This one should be full strength and ready to hit the ground running once he gets back from suspension.
Â
Player: James Robinson
Razzball Consensus ADP: 129.1
ADP Buy/Sell: Sell
Check out the link provided above for more details about the James Robinson Injury.Â
Player: Michael Gallup
Razzball Consensus ADP: 138.5
ADP Buy/Sell: Sell
Check out the link provided above for more details about the Michael Gallup Injury.Â
Player: Jameis Winston
Razzball Consensus ADP: 157.3
ADP Buy/Sell: Buy
Check out the link provided above for more details about the Jameis Winston Injury.Â
Player: Robert Woods
Razzball Consensus ADP: 110.7
ADP Buy/Sell: Sell
Check out the link provided above for more details about the Robert Woods Injury.Â
Player: Leonard Fournette
Razzball Consensus ADP: 23
ADP Buy/Sell: Sell
Check out the link provided above for more details about the Leonard Fournette Injury.Â
Player: Julio Jones
Razzball Consensus ADP: 147.1
ADP Buy/Sell: Sell
Check out the link provided above for more details about the Julio Jones Injury.Â
Sources: SportsMedAnalytics and Razzball.com